The stop-gain variant chr1:171636338 was predicted to increase expression in females and decrease expression in males for the gene MYOC, and had a CADD score of 37 and is likely pathogenic for glaucoma (Figure S12D). This evidence concerns the gene MYOC and glaucoma.